EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Rethinking control‐ IQ + technology: Simple strategies for easy optimization

Viral N Shah iD, Pratik Choudhary, Ilana Halperin, Ivana Rabbone iD, Dessi P Zaharieva iD, Laurel Messer iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70500 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Viral N Shah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Diabetes Mellitus, Type 2, Insulin Infusion Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Control‐IQ+ is an automated insulin delivery (AID) algorithm approved for people with type 1 diabetes aged 2+ years and adults aged 18+ years with type 2 diabetes. While numerous publications support improved glycaemia and quality of life for people with diabetes, this practice paper is intended to encourage uptake for healthcare professionals (HCPs) who are less familiar with AID systems. This includes recommendations for initializing settings, as well as research and practice‐based approaches to optimizing glycaemia with stronger settings (e.g., strong correction factor settings). In addition to automated insulin adjustments every 5 min, Control‐IQ+ delivers a large Autobolus up to once per hour, which can improve glycaemia in people who have challenges with routine bolusing. Simple bolus strategies and tips and tricks also highlight how to make Control‐IQ+ easy to use for HCPs and the person with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinDiabetes Mellitus, Type 2Insulin Infusion SystemsHypoglycemic AgentsHumansAlgorithmsContinuous Glucose MonitoringBlood GlucoseGlycemic ControlIntelligent SystemsBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

barrierscontinuous glucose monitoring (CGM)insulin pump therapytype 1 diabetestype 2 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Endocrinologist, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada.
  • Division of Pediatrics, Department of Health Science, University of Piemonte Orientale, Novara, Italy.
  • Division of Endocrinology & Diabetes, Stanford University, School of Medicine, Palo Alto, California, USA.

ORCID-Profile: Viral N Shah, Ivana Rabbone, Dessi P Zaharieva, Laurel Messer

Zitieren

APA

Shah, V. N., Choudhary, P., Halperin, I., Rabbone, I., Zaharieva, D. P., & Messer, L. (2026). Rethinking control‐ IQ + technology: Simple strategies for easy optimization. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70500

Vancouver

Shah VN, Choudhary P, Halperin I, Rabbone I, Zaharieva DP, Messer L. Rethinking control‐ IQ + technology: Simple strategies for easy optimization. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70500

BibTeX
@article{Shah2026,
  author = {Shah, Viral N and Choudhary, Pratik and Halperin, Ilana and Rabbone, Ivana and Zaharieva, Dessi P and Messer, Laurel},
  title = {Rethinking control‐ IQ + technology: Simple strategies for easy optimization},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70500}
}
Kostenlos starten →